Related Experiment Video
Updated: Jun 28, 2025

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
Fetal cardiac screening: 1st trimester and beyond
Lindsay R Freud1, Lynn L Simpson2
1Paediatrics, Fetal Cardiology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Insights
Routine fetal cardiac screening during pregnancy improves prenatal diagnosis of congenital heart defects (CHD), leading to better infant outcomes. Early detection through updated guidelines and technology enhances care for all risk groups.
Area of Science:
- Cardiology
- Prenatal Medicine
- Pediatrics
Background:
- Congenital heart defects (CHD) are the most common birth defect and a leading cause of infant mortality.
- CHD can occur in low-risk pregnancies, highlighting the need for universal screening.
- Prenatal diagnosis of CHD is crucial for informed decision-making and optimal perinatal management.
Purpose of the Study:
- To review current practices and advancements in fetal cardiac screening throughout pregnancy.
- To emphasize the importance of routine screening in all pregnant patients.
- To discuss the evolving trend of first-trimester screening for high-risk populations.
Main Methods:
- Review of updated fetal cardiac screening guidelines.
- Discussion of technological advancements in prenatal imaging.
- Analysis of educational efforts to improve CHD detection rates.
Main Results:
- Updated guidelines and technology have increased prenatal detection of CHD in both low- and high-risk groups.
- Prenatal diagnosis has demonstrably improved neonatal and infant outcomes.
- First-trimester screening is emerging for specific high-risk groups.
Conclusions:
- Routine fetal cardiac screening is vital for early detection and management of CHD.
- Continued advancements and expanded screening protocols are expected to further improve outcomes.
- Prenatal diagnosis of CHD significantly benefits affected infants and families.
Abstract:
Congenital heart defects (CHD) are the most common birth defect and a leading cause of infant morbidity and mortality. CHD often occurs in low-risk pregnant patients, which underscores the importance of routine fetal cardiac screening at the time of the 2nd trimester ultrasound. Prenatal diagnosis of CHD is important for counseling and decision-making, focused diagnostic testing, and optimal perinatal and delivery management. As a result, prenatal diagnosis has led to improved neonatal and infant outcomes. Updated fetal cardiac screening guidelines, coupled with technological advancements and educational efforts, have resulted in increased prenatal detection of CHD in both low- and high-risk populations. However, room for improvement remains. In recent years, fetal cardiac screening for specific high-risk populations has started in the 1st trimester, which is a trend that is likely to expand over time. This review discusses fetal cardiac screening throughout pregnancy.
Related Concept Videos
Development of the Heart
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
Teratogenicity
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Ultrasonography
During an ultrasonography procedure, a handheld device called...
Development of Blood Vessels
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...

